RIME
Algorhythm Holdings, Inc.
There isn't enough reported data to score RIME yet.
RIME Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Healthy |
RIME's balance sheet is currently healthy, but its revenue, profitability and cash flow are under pressure.
RIME PE Valuation
RIME has no meaningful PE right now: it lost money over the past year.
RIME Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect RIME's losses to shrink, with revenue growing.
RIME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.14 | +$328.44 |
| Q1 2026 | -$3.13 | +$518.21 |
| Q4 2025 | -$7.27 | +$583.41 |
| Q3 2025 | -$358.73 | +$2.86 |
| Q2 2025 | -$331.58 | +$52.01 |
| Q1 2025 | -$521.34 | -$199.75 |
| Q4 2024 | -$590.68 | -$123.09 |
| Q3 2024 | -$361.59 | +$106.41 |
RIME is still losing money, but far less than before: $3.14 per share over the past year, against $590.68 at its worst in late 2024.
RIME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +11% |
| Q1 2026 | $2.4M | +20% |
| Q4 2025 | $1.4M | -83% |
| Q3 2025 | $1.7M | -84% |
| Q2 2025 | $2.7M | +11% |
| Q1 2025 | $2M | -18% |
| Q4 2024 | $8M | -25% |
| Q3 2024 | $10.6M | -33% |
RIME's revenue is recovering but still below its 2020 peak: $3M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -90% | -61 points |
| Q1 2026 | -181% | -40 points |
| Q4 2025 | -296% | -212 points |
| Q3 2025 | -90% | -102 points |
| Q2 2025 | -29% | +223 points |
| Q1 2025 | -141% | -47 points |
| Q4 2024 | -84% | -48 points |
| Q3 2024 | 12% | +11 points |
RIME's operating margin was −90% last quarter, down 61 points from the same quarter a year ago.
RIME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$3.9M | -$828K |
| Q4 2025 | -$3M | -$1.5M |
| Q3 2025 | $1.1M | +$2.8M |
| Q4 2024 | -$1.5M | -194% |
| Q3 2024 | -$1.7M | -228% |
| Q4 2023 | $1.6M | +26% |
| Q3 2023 | $1.3M | +168% |
| Q2 2023 | -$2.6M | +$1.6M |
RIME has burned cash in most quarters: −$8M over the past year, against −$5M the year before.
RIME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +53% | +5.3M shares |
| 1 year | +513% | +12.7M shares |
| 3 years | +96818% | +15.1M shares |
| 5 years | +232307% | +15.1M shares |
| Available history | +230925% | +15.1M shares |
RIME has 15M diluted shares, up 513% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
RIME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -0.2x | Net Cash |
| Q2 2022 | 0.6x | Very low |
| Q1 2022 | 0.8x | Very low |
| Q4 2021 | 2.5x | Moderate |
| Q3 2021 | -4.2x | Net Cash |
| Q2 2021 | -0.5x | Net Cash |
| Q1 2021 | 0.1x | Very low |
| Q4 2020 | -0.2x | Net Cash |
RIME has more cash than debt.
RIME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.9 | Neutral |
| Stochastic | 7.8 | Oversold |
RIME's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
RIME PE vs Technology Sector
| Metric | RIME | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
RIME has no meaningful PE right now: it lost money over the past year.
RIME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.13 | 7.7% above |
| 20 week MA | $0.28 | 50% below |
| 50 week MA | $0.82 | 83% below |
| 100 week MA | $2.45 | 94% below |
| 200 week MA | $124.4 | 100% below |
RIME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 100% below its 200-week average.
RIME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,441.4 | $1,982.0 | +38% |
| 2021 | $1,982.0 | $1,321.9 | -33% |
| 2022 | $1,321.9 | $998.0 | -25% |
| 2023 | $998.0 | $202.0 | -80% |
| 2024 | $202.0 | $16.8 | -92% |
| 2025 | $16.8 | $1.13 | -93% |
| 2026 YTD | $1.13 | $0.14 | -88% |
RIME has finished five years in a row lower, and it's down 88% so far in 2026.